
Medical Innovation Xchange Welcomes Foqus Technologies Inc. as Its Newest Affiliate Company
Kitchener, Ontario – March 20th, 2026, Medical Innovation Xchange (MIX) is thrilled to welcome Foqus Technologies Inc. as the newest affiliate company in our growing ecosystem of Canadian med‑tech innovators. Toronto‑based Foqus joins MIX at a pivotal moment in their journey, bringing a bold vision for transforming magnetic resonance imaging (MRI) through advanced software innovation.
Foqus is redefining what’s possible in MRI with its FDA‑cleared technology that leverages proprietary AI and quantum‑enabled algorithms to reduce scan times from around 40 minutes to under 10 minutes. By dramatically accelerating imaging without requiring costly hardware upgrades, Foqus empowers healthcare providers to increase scanner throughput, reduce wait times, and improve patient access to high‑quality diagnostic care.
This breakthrough represents a major leap forward for MRI efficiency and accessibility, offering a scalable, cost‑effective solution that aligns with the future of value‑based healthcare.
By joining MIX, Foqus gains access to founders and teams who understand the complexities of building, validating, and commercializing regulated medical technologies in Canada and beyond.
“As we grow and focus more on our go‑to‑market strategies, MIX is a perfect program for our stage,” the Foqus team shared. “MIX offers experienced mentors, training programs, and a community of experts with real‑world experience aligned to our needs. We joined MIX to be part of a strong innovation ecosystem and learn alongside industry leaders to accelerate our product and business efforts.”
Foqus is eager to collaborate with MIX companies, especially in refining and executing their go‑to‑market strategy, expanding their network, and strengthening partnerships that support scalable clinical adoption. As they advance toward broader deployment, Foqus is building relationships and commercialization pathways needed to bring their technology to more providers and patients.
We’re excited to support Foqus Technologies Inc. as they continue advancing MRI innovation and scaling their solution toward meaningful clinical impact. Their mission aligns deeply with MIX’s vision. Click here to learn more or to join MIX. Visit MIX Programs for more information.



